Equity-Linked

  • Chinese pharma names flock to ECM market

    Chinese pharma names flock to ECM market

    There was a burst of activity from Chinese pharmaceutical and biotechnology companies in the equity capital markets this week, as the sector took centre stage following the spread of a flu-like virus that has already claimed lives on the mainland. Jonathan Breen reports.

  • Sino Biopharm nets €750m from debut CB

    Sino Biopharm nets €750m from debut CB

    Sino Biopharmaceutical issued a zero coupon convertible bond on Wednesday, boosting the size to €750m as demand poured in from across Asia, Europe and the US, according to multiple sources close to the deal.

  • Anta Sports defies short seller shadow with €1bn CB

    Anta Sports defies short seller shadow with €1bn CB

    Anta Sports Products made a stellar euro equity-linked debut this week, sealing a €1bn zero-coupon convertible bond at a negative yield. The deal had its share of challenges, but showed what is possible in a market that has seen a change in sentiment recently. Jonathan Breen reports.

  • Innolux lands $300m from convertible bond

    Innolux lands $300m from convertible bond

    Taiwanese LCD panel maker Innolux Corp raised $300m from a zero coupon convertible bond this week, riding a new wave of demand for the asset class in 2020.

  • Anta Sports jumps over hurdles for €1bn CB

    Anta Sports jumps over hurdles for €1bn CB

    Anta Sports Products, a Chinese sportswear manufacturer and retailer, had to navigate a number of roadblocks to print a €1bn zero coupon convertible bond to refinance loans in the currency.

  • Anta Sports launches €1bn zero coupon CB

    Anta Sports launches €1bn zero coupon CB

    Hong Kong-listed Anta Sports Products hit the market with a €1bn convertible bond on Monday after the close of business, according to a term sheet seen by GlobalCapital Asia.

Equity-linked archive